Literature DB >> 31581159

In brief: Risk of pulmonary thromboembolism and death with tofacitinib.

.   

Abstract

Entities:  

Keywords:  Olumiant; TNF inhibitors; Xeljanz; adverse effects; baricitinib; dosage; drug safety; efficacy; psoriatic arthritis; rheumatoid arthritis; safety; tofacitinib; ulcerative colitis

Mesh：

Substances：

Year:  2019        PMID： 31581159

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  2 in total

1.  A transcriptomic map of murine and human alopecia areata.

Authors:  Nicholas Borcherding; Sydney B Crotts; Luana S Ortolan; Nicholas Henderson; Nicholas L Bormann; Ali Jabbari
Journal:  JCI Insight       Date:  2020-07-09

Review 2.  Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.

Authors:  Serena Colafrancesco; Rossana Scrivo; Cristiana Barbati; Fabrizio Conti; Roberta Priori
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.